|
|
|
|
Search
12/15/2021 Paul Kesselman, DPM
Best Treatment Option Status Post Transmet Amputation (Jeffrey Kass, DPM)
I see almost no value in stuffing a shoe with who knows what materials, either on the advice of a general or orthopedic surgeon as I have seen over the past forty years. This almost never helps patients and almost always creates more harm than good. I have seen this overly simplistic attempt at causing everything from mild inflammation affecting the distal stump to frank ulceration.
To say nothing of the fact that this does nothing to offer the patient any assistance in any gait abnormalities which the patient may have. This leaves the reasonable practitioner to investigate whether a custom toe filler with or without a carbon plate to stiffen the shoe is best, or does the patient require an AFO with toe filler with a stiff shoe plate.
In almost every TMA I performed, I also either at the time of TMA or some months shortly thereafter performed either a STAAT and T Achilles Percutaneous lengthening. My patients were counseled on this prior to the performance of the TMA as part of a staged addressing of their issues as well as discussing their gait assistive devices prior to surgery. In many cases, this approach afforded the ability to really keep things simple and those patients in most cases did fine with a custom made toe filler with carbon plate shoe stiffener over the long term.
In those cases where the equinus and varus were not surgically managed or could not be, an AFO with a toe filler worked best, not perfect but as best as could be expected.
Having seen many patients who underwent surgery elsewhere, the last thing they want to hear is that they need more surgery and in many cases the risks are too high.
Certainly each patient needs their own independent evaluation and let us not forget many of them have mechanical issues which go beyond the lower extremity.
Thus to simply catalog patients into one category or another is no doubt over simplistic. The whole package needs to be addressed.
Last but not least, don't overlook an examination of the patient's shoes. That too many provide you with invaluable information.
To sum things up, I think this is a great question and I am looking forward to hearing from others on providing their expertise and the offering of their experiences.
Paul Kesselman, DPM, Oceanside, NY
Other messages in this thread:
12/16/2021 Doug Richie, DPM
Best Treatment Option Status Post Transmet Amputation (Jeffrey Kass, DPM)
It should be recognized that the current preferred treatment of the post TMA patient, using therapeutic shoes with toe fillers is simply inadequate. Consider a systematic review which showed that one-third of patients undergoing a TMA will require a more proximal amputation of their affected lower extremity within 5 years. (Thorud, Jakob C.; Jupiter, Daniel C.; Lorenzana, Jonathan; Nguyen, Tea Tu; Shibuya, Naohiro. Reoperation and reamputation after transmetatarsal amputation: A systematic review. The Journal of Foot & Ankle Surgery;2016, 55: 1007–1012) There are several reasons for the high ulceration rate in patients who have undergone a TMA procedure. Studies have documented high plantar pressures in the residual foot compared to the contralateral foot in TMA patients. This may be related to substantial gait disturbances which have been observed in TMA patients. Mueller and co- workers studied patients with diabetes and TMA and found less range of motion, lower peak moments and diminished power at the ankle compared to age matched controls.
(Mueller MJ Salsich GB, Bastian AJ. Differences in the gait characteristics of people with diabetes and transmetatarsal amputation compared with age- matched controls Gait and Posture.1998;7: 200–206) In this same study, the TMA patients had only 25% the push-off power of healthy controls. One of the significant changes that occur after forefoot amputation is the shortening of the plantar flexion lever arm of the triceps surae acting on the foot. Another factor is the loss of tendon attachments at the toes, and sometimes within the mid-foot creating a functional dropfoot condition. An imbalance occurs where the tibialis anterior muscle overpowers the peroneus longus and inverts the foot ,creating a varus deformity. Stiff rocker soles are thought to help offset some of these structural and functional changes after a TMA, but they do not adequately replace the imbalance and loss of the ankle joint plantar flexion and dorsiflexion muscle-tendon units. That is why a system which incorporates a carbon fiber AFO with a custom foot orthoses and toe filler can address all components of the biomechanical deficits seen in the post TMA patient. A carbon graphite ankle-foot orthosis is capable of maintaining ankle joint dorsiflexion during swing phase while providing dynamic recoil at late mid-stance to aid in push-off during the heel rise phase of gait. This type of ankle foot orthosis contains a full length carbon graphite foot plate to re-establish and lengthen the lost lever arm for ankle plantar flexion seen in TMA patients. The solid connection of the lower leg portion of the ankle foot orthosis to the full length foot plate facilitates the “third rocker” phase of gait which is lost in the TMA patient. A custom molded partial foot orthosis with toe filler and medial posting is the second component of the system to provide total contact off loading of the residual varus foot for reduction of plantar pressure and tangential shear force.
Finally, properly fitted footwear is essential to accommodate this orthotic system and address the needs of the contralateral foot. Disclosure: I am the owner of Richie Technologies Inc who distribute carbon fiber ankle-foot orthotic systems.
Doug Richie, DPM, Long Beach, CA
|
| |
|
|